ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,600, issued on Nov. 11, was assigned to Xeolas Pharmaceuticals Ltd. (Dublin).
"Pediatric suspension formulation" was invented by Dennis Mark Mcdaid (Dublin), Damien Patrick Flynn (Dublin) and Maurice Joseph Anthony Clancy (Dublin).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to storage-stable proton pump inhibitor (PPI) systems comprising a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, which are constituted with water prior to administration. The present disclosure also relates to oral pharmaceutical suspension...